ABSTRACT
Cardiac arrest is a common disease in the United States, and many patients will die
as a result of the neurological damage suffered during the anoxic period, or will
live in a neurologically debilitated state. When cardiopulmonary-cerebral resuscitation
results in the return of spontaneous circulation, intensive care is required to optimize
neurological recovery. Such “brain-oriented” therapies include routine care, such
as positioning and maintenance of volume status; optimization of cerebral perfusion,
with the use of vasopressors if needed; management of increased intracranial pressure
with agents such as hypertonic saline; assuring adequate oxygenation and avoiding
hypercapnia; aggressive fever control; intensive glucose control, with the use of
an insulin drip if needed; and management of seizures if they occur. To date, no neuroprotectant
medications have been shown to improve neurological outcome. Induced moderate therapeutic
hypothermia is utilized as a neuroprotective maneuver. Future treatment options and
advanced monitoring techniques are also discussed. Further study to optimize neuroprotective
strategies when treating patients who survive cardiac arrest is needed.
KEYWORDS
Postresuscitation - cardiopulmonary-cerebral resuscitation (CPCR) - cardiac arrest
REFERENCES
- 1 O'Neil B J, Krause G S, Grossman L I et al..
Global brain ischemia and reperfusion by cardiac arrest and resuscitation. In: Paradis N, Halpern H, Nowak R Cardiac Arrest: The Science and Practice of Resuscitation
Medicine. Baltimore: Williams and Wilkins 1996: 84-112
- 2
Herlitz J, Andersson E, Bang A et al..
Experiences from treatment of out-of-hospital cardiac arrest during 17 years in Goteborg
[see comments].
Eur Heart J.
2000;
21
1251-1258
- 3
Krause G S, Kumar K, White B C et al..
Ischemia, resuscitation, and reperfusion: mechanisms of tissue injury and prospects
for protection.
Am Heart J.
1986;
111
768-780
- 4
Pusswald G, Fertl E, Faltl M, Auff E.
Neurological rehabilitation of severely disabled cardiac arrest survivors: Part II.
Life situation of patients and families after treatment.
Resuscitation.
2000;
47
241-248
- 5
Advances in cardiovascular life support-section 8: postresuscitation care.
Circulation.
2000;
102(suppl I)
I166-I177
- 6
Safar P.
On the history of modern resuscitation.
Crit Care Med.
1996;
24(suppl)
S3-S11
- 7
Bell D D, Brindley P G, Forrest D, Al Muslin O, Zygun D.
Management following resuscitation from cardiac arrest: recommendations from the 2003
Rocky Mountain Critical Care Conference.
Can J Anaesth.
2005;
52
309-322
- 8
Sundgreen C, Larsen F S, Herzog T M et al..
Autoregulation of cerebral blood flow in patients resuscitated from cardiac arrest.
Stroke.
2001;
32
128-132
- 9
Mullner M, Sterz F, Binder M et al..
Arterial blood pressure after human cardiac arrest and neurological recovery.
Stroke.
1996;
27
59-62
- 10
Sterz F, Leonov Y, Safar P et al..
Hypertension with or without hemodilution after cardiac arrest in dogs.
Stroke.
1990;
21
1178-1184
- 11
Bhardwaj A, Ulatowski J.
Hypertonic saline solutions in brain injury.
Curr Opin Crit Care.
2004;
10
126-131
- 12
Sakabe T, Tateishi A, Miyauchi Y et al..
Intracranial pressure following cardiopulmonary resuscitation.
Intensive Care Med.
1987;
13
256-259
- 13 Bhardwaj A.
Cerebral edema and intracranial hypertension. In: Bhardwaj A, Mirski MA, Ulatowski JA Handbook of Neurocritical Care. Totowa,
NJ; Humana Press 2004
- 14 Ropper A H, Rockoff M A.
Physiological and clinical aspects of raised intracranial pressure. In: Ropper AH Neurological and Neurosurgical Intensive Care. 3rd ed. New York; Raven
Press 1993: 11-28
- 15
Ausina A, Baguena M, Nadal M et al..
Cerebral hemodynamic changes during sustained hypocapnia in severe head injury: can
hyperventilation cause cerebral ischemia?.
Acta Neurochir Suppl.
1998;
71
1-4
- 16
Diringer M N, Yundt K, Videen T O et al..
No reduction in cerebral metabolism as a result of early moderate hyperventilation
following severe traumatic brain injury.
J Neurosurg.
2000;
92
7-13
- 17
Yundt K D, Diringer M N.
The use of hyperventilation and its impact on cerebral ischemia in the treatment of
traumatic brain injury.
Crit Care Clin.
1997;
13
163-184
- 18
Grubb N R.
Managing out-of-hospital cardiac arrest survivors: 1. Neurological perspective.
Heart.
2001;
85
6-8
- 19
Zeiner A, Holzer M, Sterz F et al..
Hyperthermia after cardiac arrest is associated with an unfavorable neurologic outcome.
Arch Intern Med.
2001;
161
2007-2012
- 20
Eisenburger P, Sterz F, Holzer M et al..
Therapeutic hypothermia after cardiac arrest.
Curr Opin Crit Care.
2001;
7
184-188
- 21
Sieber F E, Traystman R J.
Special issues: glucose and the brain.
Crit Care Med.
1992;
20
104-114
- 22
Parsons M W, Barber P A, Desmond P M et al..
Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging
and spectroscopy study.
Ann Neurol.
2002;
52
20-28
- 23
Weir C J, Murray G D, Dyker A G, Lees K R.
Is hyperglycemia an independent predictor of poor outcome after acute stroke? Results
of a long-term follow-up study.
BMJ.
1997;
314
1303-1306
- 24
Williams L S, Rotich J, Qi R et al..
Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke.
Neurology.
2002;
59
67-71
- 25
Woo E, Chan Y W, Yu Y L, Huang C Y.
Admission glucose level in relation to mortality and morbidity outcome in 252 stroke
patients.
Stroke.
1988;
19
185-191
- 26
Longstreth W T, Inui T S, Cobb L A, Compass M K.
Neurologic recovery after out-of-hospital cardiac arrest.
Ann Intern Med.
1983;
98
588-592
- 27
Longstreth Jr W T, Copass M K, Dennis L K et al..
Intravenous glucose after out-of-hospital cardiopulmonary arrest: a community-based
randomized trial.
Neurology.
1993;
43
2534-2541
- 28
Van den Berghe G, Wouters P, Weekers F et al..
Intensive insulin therapy in critically ill patients.
N Engl J Med.
2001;
345
1359-1367
- 29 Longstreth W T.
Neurologic complications of cardiac arrest. In: Aminoff MJ Neurology and General Medicine. 3rd ed. Philadelphia; Churchill Livingstone
2001: 151-170
- 30
Celesia G G, Grigg M M, Ross E.
Generalized status myoclonus in acute anoxic and toxic-metabolic encephalopathies.
Arch Neurol.
1988;
45
781-784
- 31
Krumholz A, Stern B J, Weiss H D.
Outcome from coma after CPR: relation to seizures and myoclonus.
Neurology.
1988;
38
401-405
- 32
Arnoldus E PJ, Lammers G J.
Postanoxic coma: good recovery despite myoclonic status.
Ann Neurol.
1995;
38
697-698
- 33
Wijdicks E FM, Parisi J E, Sharbrough F W.
Prognostic value of myoclonus status in comatose survivors of cardiac arrest.
Ann Neurol.
1994;
35
239-243
- 34
Buunk G, van der Hoeven J G, Meinders A E.
Cerebral blood flow after cardiac arrest.
Neth J Med.
2000;
57
106-112
- 35
Werhahn K J, Brown P, Thompson P D, Marsden C D.
The clinical features and prognosis of chronic posthypoxic myoclonus.
Mov Disord.
1997;
12
216-220
- 36
Krumholz A, Berg A.
Further evidence that for status epilepticus “one size fits all” doesn't fit.
Neurology.
2002;
58
515-516
- 37
Jörgensen E O, Holm S.
Prediction of neurological outcome after cardiopulmonary resuscitation.
Resuscitation.
1999;
41
145-152
- 38
Goh W C, Heath P D, Ellis S J, Oakley P A.
Neurologic outcome prediction in a cardiorespiratory arrest survivor.
Br J Anaesth.
2002;
88
719-722
- 39
Young G B, Gilbert J J, Zochodne D W.
The significance of myoclonic status epilepticus in postanoxic coma.
Neurology.
1990;
40
1843-1848
- 40
Bernard S A, Gray T W, Buist M D et al..
Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.
N Engl J Med.
2002;
346
557-563
- 41
Longstreth W T, Fahrenbruch C E, Olsufka M et al..
Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac
arrest.
Neurology.
2002;
59
506-514
- 42
Lindner K H, Dirks B, Strohmenger H U et al..
Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital
ventricular fibrillation.
Lancet.
1997;
349
535-537
- 43
Gueugniaud P Y, Mols P, Goldstein P et al..
A comparison of repeated high doses and repeated standard doses of epinephrine for
cardiac arrest outside the hospital. European Epinephrine Study Group.
N Engl J Med.
1998;
339
1595-1601
- 44
Stiell I G, Hebert P C, Wells G A et al..
Vasopressin versus epinephrine for inhospital cardiac arrest: a randomized controlled
trial.
Lancet.
2001;
358
105-109
- 45
A randomized clinical trial of calcium entry blocker administration to comatose survivors
of cardiac arrest: design, methods, and patient characteristics. The Brain Resuscitation
Clinical Trial II Study Group.
Control Clin Trials.
1991;
12
525-545
- 46
Jastremski M, Sutton-Tyrrell K, Vaagenes P et al..
Glucocorticoid treatment does not improve neurological recovery following cardiac
arrest. Brain Resuscitation Clinical Trial I Study Group.
JAMA.
1989;
262
3427-3430
- 47
Safar P.
On the history of modern resuscitation.
Crit Care Med.
1996;
24(suppl)
S3-S11
- 48
Bottiger B W, Martin E.
Thrombolytic therapy during cardiopulmonary resuscitation and the role of coagulation
activation after cardiac arrest.
Curr Opin Crit Care.
2001;
7
176-183
- 49
Koehler R C, Michael J R.
Cardiopulmonary resuscitation, brain blood flow and neurologic recovery.
Crit Care Clin.
1985;
1
205-222
- 50
Cohan S L, Mun S K, Petite J.
Cerebral blood flow in humans following resuscitation from cardiac arrest.
Stroke.
1989;
20
761-765
- 51
Lee S K, Vaagenes P, Safar P.
Effect of cardiac arrest time on cortical cerebral blood flow during subsequent standard
external cardiopulmonary resuscitation in rabbits.
Resuscitation.
1989;
17
105-117
- 52
Safar P.
Cerebral resuscitation after cardiac arrest: research initiatives and future directions.
Ann Emerg Med.
1993;
22
324-349
- 53
Sterz F, Leonov Y, Safar P et al..
Multifocal cerebral blood flow by Xe-CT and global cerebral metabolism after prolonged
cardiac arrest in dogs: reperfusion with open-chest CPR or cardiopulmonary bypass.
Resuscitation.
1992;
24
27-47
- 54
Schreiber W, Gabriel D, Sterz F et al..
Thrombolytic therapy after cardiac arrest and its effect on neurological outcome.
Resuscitation.
2002;
52
63-69
- 55
Hekmatpanah J.
Cerebral blood flow dynamics in hypotension and cardiac arrest.
Neurology.
1973;
23
174-180
- 56
Bottiger B W, Motsch J, Bohrer H et al..
Activation of blood coagulation after cardiac arrest is not balanced adequately by
activation of endogenous fibrinolysis.
Circulation.
1995;
92
2572-2578
- 57
Van Campen L CMC, van Leeuwen G R, Verheugt F WA.
Safety and efficacy of thrombolysis for acute myocardial infarction in patients with
prolonged out-of-hospital cardiopulmonary resuscitation.
Am J Cardiol.
1994;
73
953-955
- 58
Gore J M, Sloan M, Price T R et al..
Intracerebral hemorrhage, cerebral infarction and subdural hematoma after acute myocardial
infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study.
Circulation.
1991;
83
448-459
- 59
Scholz K H, Tebbe U, Herrmann C et al..
Frequency of complications of cardiopulmonary resuscitation after thrombolysis during
acute myocardial infarction.
Am J Cardiol.
1992;
69
724-728
- 60
Bottiger B W, Bode C, Kern S et al..
Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary
resuscitation: a prospective clinical trial.
Lancet.
2001;
357
1583-1585
- 61
Kariman K, Hempel F G, Jobsis F F.
In vivo comparison of cytochrome a/a3 redox states and tissue pO2 in transient anoxia.
J Appl Physiol.
1983;
55
1057-1063
- 62
Kiening K L, Unterberg A W, Bardt T F et al..
Monitoring of cerebral oxygenation in patients with severe head injuries: brain tissue
pO2 versus jugular vein oxygen saturation.
J Neurosurg.
1996;
85
751-757
- 63
Dings J, Meixensberger J, Amschler J, Hamelbeck B, Roosen K.
Brain tissue pO2 in relation to cerebral perfusion pressure, TCD findings and TCD-CO2
reactivity after severe head injury.
Acta Neurochir (Wien).
1996;
138
425-434
- 64
Gopinath S P, Valadka A B, Uzura M et al..
Comparison of jugular venous oxygen saturation and brain tissue pO2 as monitors of
cerebral ischemia.
Crit Care Med.
1999;
27
2337-2345
- 65
Goodman J C, Valadka A B, Gopinath S P, Uzura M, Robertson C S.
Extracellular lactate and glucose alterations in the brain after head injury measured
by microdialysis.
Crit Care Med.
1999;
27
1965-1973
- 66
Lewis K S, Kane-Gill S L, Bobek M B, Dasta J F.
Intensive insulin therapy for critically ill patients.
Ann Pharmacother.
2004;
38
1243-1251
Wendy L WrightM.D.
Assistant Professor, Neuroscience Critical Care and Cerebrovascular Disease, Departments
of Neurology and Neurosurgery, Emory University Hospital
1365B Clifton Road, NE, Suite 2200, Atlanta, GA 30322